Drug Shortage Report for COTAZYM ECS 8

Last updated on 2023-01-19 History
Report ID 166775
Drug Identification Number 00502790
Brand name COTAZYM ECS 8
Common or Proper name PANCRELIPASE DELAYED-RELEASE CAPSULES
Company Name ORGANON CANADA INC.
Market Status MARKETED
Active Ingredient(s) PROTEASE AMYLASE LIPASE
Strength(s) 45000UNIT 42000UNIT 10800UNIT
Dosage form(s) CAPSULE (DELAYED RELEASE)
Route of administration ORAL ORAL
Packaging size 500
ATC code A09AA
ATC description DIGESTIVES, INCL ENZYMES
Reason for shortage Shortage of an active ingredient.
Anticipated start date 2022-11-07
Actual start date 2022-10-26
Estimated end date 2023-02-24
Actual end date 2023-01-18
Shortage status Resolved
Updated date 2023-01-19
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 16766 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-844-820-5468 dpoc.canada@organon.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-08-15 English Compare
v2 2022-08-15 French Compare
v3 2022-10-26 English Compare
v4 2022-10-26 French Compare
v5 2022-10-27 English Compare
v6 2022-11-08 English Compare
v7 2022-11-08 French Compare
v8 2022-11-10 English Compare
v9 2022-11-10 French Compare
v10 2022-12-13 English Compare
v11 2022-12-13 French Compare
v12 2023-01-10 English Compare
v13 2023-01-10 French Compare
v14 2023-01-18 English Compare
v15 2023-01-18 French Compare
v16 2023-01-19 English Compare

Showing 1 to 16 of 16